Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Atherosclerosis and Thrombosis"
DOI: 10.5551/jat.42481
Abstract: Aim: Dipeptidyl peptidase-4 (DPP-4) inhibitors lower blood glucose levels through inhibition of incretin degradation, which stimulates insulin secretion. Recent studies reported that DPP-4 inhibitors suppressed atherogenesis in apolipoprotein E-knockout (ApoEKO) mice. In this study, we…
read more here.
Keywords:
teneligliptin;
control;
formation;
mice ... See more keywords